Heart failure treatment in the elderly

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 9, 2011, Pages 1171-1179

  Khangura, Jessi ^a   Goodlin, Sarah J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

aging; device therapy; elderly; heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST;

AGED; CONSERVATIVE TREATMENT; ELDERLY CARE; EPIDEMIC; HEART FAILURE; HUMAN; MUSCLE TRAINING; REVIEW; SODIUM RESTRICTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; HEART FAILURE; HUMANS;

EID: 80053124276     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.128     Document Type: Review

References (69)

1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 123(4), e18-e209 (2011).
2. Maisel A, Mueller C, Adams K et al. State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 10(9), 824-839 (2008).
3. deFilippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL. Dynamic cardiovascular risk assessment in elderly people: the role of repeated N-terminal pro B-type natriuretic peptide testing. J. Am. Coll. Cardiol. 55(5), 441-450 (2010).
4. Maisel AS, Clopton P, Krishnaswamy P et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study. Am. Heart J. 147(6), 1078-1084 (2004). (Pubitemid 38880968)
5. Bean JF, Kiely DK, Leveille SG et al. The 6-minute walk test in mobility-limited elders: what is being measured? J. Gerontol. 57A(11), M751-M756 (2002). (Pubitemid 35340557)
6. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and post-infarction left ventricular remodeling. J. Am. Coll. Cardiol. 57(1), 9-17 (2011).
7. Sangaralingham SJ. Myocardial fibrosis and CNP with age. Hypertension 57, 201 (2011).
8. Kinney JM. Nutritional frailty, sarcopenia and falls in the elderly. Curr. Opin. Clin. Nutr. Metab. Care 7(1), 15-20 (2004). (Pubitemid 40348178)
9. Rozzini R, Sabatini T, Frisoni GB, Trabucchi M. Frailty is a strong modulator of heart failure-associated mortality. Arch. Intern. Med. 163(6), 737-738; author reply 738 (2003). (Pubitemid 36343370)
10. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype6A(7). J. Gerontol. MS M146-M156 (2001). (Pubitemid 32187141)
11. Chiarantini D, Volpato S, Sioulis F et al. Lower extremity performance measures predict long term prognosis in older patients hospitalized for heart failure. J. Card. Fail. 16, 390-395 (2010).
12. Pulignano G, Del Sindaco D, Tavazzi L et al. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am. Heart J. 143(1), 45-55 (2002). (Pubitemid 34056374)
13. Rich MW. Management of heart failure in the elderly. Heart Fail. Rev. 7(1), 89-97 (2002). (Pubitemid 34154902)
14. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch. Intern. Med. 157(19), 2242-2247 (1997). (Pubitemid 27451150)
15. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch. Intern. Med. 162(15), 1682-1688 (2002).
16. Bierman AS. Coexisting illness and heart disease among elderly Medicare managed care enrollees. Health Care Financ. Rev. 25(4), 105-117 (2004). (Pubitemid 39201559)
17. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction: a meta-analysis. J. Am. Coll. Cardiol. 57(16), 1676-1686 (2011).
18. Lainscak M, Moullet C, Schon N, Tendera M. Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience. Int. J. Cardiol. 122(2), 149-155 (2007). (Pubitemid 47552591)
19. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients. Heart Dis. 5(4), 279-294 (2003). (Pubitemid 36944833)
20. Flather MD, Shibata MC, Coats AJ et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 26(3), 215-225 (2005). (Pubitemid 40222359)
21. Ambrosio G FM, Bohm M et al. b-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3), 209-214 (2011).
22. Erdmann E, Lechat P, Verkenne P, Wiemann H. Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur. J. Heart Fail. 3(4), 469-479 (2001). (Pubitemid 32776874)
23. Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC. Efficacy, safety and tolerability of b-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur. Heart J. 25(15), 1300-1309 (2004). (Pubitemid 38998506)
24. Krum H, Hill J, Fruhwald F et al. Tolerability of b-blockers in elderly patients with chronic heart failure: the COLA II study. Eur. J. Heart Fail. 8(3), 302-307 (2006).
25. Witham MD, Gillespie ND, Struthers AD. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Age Ageing 33(5), 467-472 (2004). (Pubitemid 39214274)
26. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273(18), 1450-1456 (1995).
27. Flather MD, Yusuf S, Kober L et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355(9215), 1575-1581 (2000). (Pubitemid 30240501)
28. Cleland Jgf TM, Adamus J, Freemantle N, Polonski L, Taylor, J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J. 27, 2338-2345 (2006). (Pubitemid 44453578)
29. Ferrari R. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study. Arch. Intern. Med. 166(6), 659-666 (2006).
30. Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD, Mcmurdo ME. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 88(4), 373-377 (2002).
31. Sumukadas D, Witham MD, Struthers AD, Mcmurdo MET. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. Can. Med. Assoc. J. 177(8), 867-874 (2007). (Pubitemid 47612819)
32. Dulin BR. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Curr. Opin. Cardiol. 21, 393-399 (2006). (Pubitemid 44315073)
33. Baruch L, Glazer RD, Aknay N et al. Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT). Am. Heart J. 148(6), 951-957 (2004). (Pubitemid 39646966)
34. OMeara E, Solomon S, McMurray J et al. Effect of candesartan on New York Heart Association functional class. Eur. Heart J. 35, 1920-1926 (2004).
35. Massie BM, Carson PE, McMurray JJ et al.; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med. 359, 2456-2467 (2008).
36. Pitt B, Segal R, Martinez FA et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349(9054), 747-752 (1997). (Pubitemid 27122456)
37. Simpson KL. Losartan: a review of its use, with special focus on elderly patients. Drugs Aging 3, 227-250 (2000). (Pubitemid 30166922)
38. Pitt B, Poole-Wilson PA, Segal R et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial: the Losartan Heart Failure Survival Study ELITE II. Lancet 355(9215), 1582-1587 (2000). (Pubitemid 30240502)
39. Damman K, Ng Kam Chuen MJ, Macfadyen RJ et al. Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J. Am. Coll. Cardiol. 57(22), 2233-2241
40. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341(10), 709-717 (1999). (Pubitemid 29407370)
41. Packer M, Poole-Wilson PA, Armstrong PW et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100, 2312-2318 (1999).
42. Gheorghiade M, Zannad F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112(25), 3958-3968 (2005). (Pubitemid 43739494)
43. Troughton RW, Frampton CM, Nicholls MG. Biomarker-guided treatment of heart failure: still waiting for a definitive answer. J. Am. Coll. Cardiol. 56(25), 2101-2104 (2010).
44. Lainchbury JG, Troughton RW, Strangman KM et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J. Am. Coll. Cardiol. 55(1), 53-60 (2009).
45. Howard PA, Dunn MI. Severe musculoskeletal symptoms during continuous infusion of bumetanide. Chest 111(2), 359-364 (1997). (Pubitemid 27096951)
46. Felker Gm LK, Bull Da, Et al. Diuretic strategies in patients with acute decompensated heart failure. N. Engl. J. Med. 364(9), 797-805 (2011).
47. Howard PA, Dunn MI. Severe heart failure in the elderly: potential benefits of high-dose and continuous infusion diuretics. Drugs Aging 19(4), 249-256 (2002). (Pubitemid 34686719)
48. Zannad F. Randomized trial of eplerenone in mild heart failure. N. Engl. J. Med. (2010) (Epub ahead of print).
49. Tresch DD, Mcgough MF. Heart failure with normal systolic function: a common disorder in older people. J. Am. Geriatr. Soc. 43(9), 1035-1042 (1995).
50. Hunt SA, Abraham WT, Chin MH et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 53(15), e1-e90 (2009).
51. Rich MW, Mcsherry F, Williford WO, Yusuf S. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J. Am. Coll. Cardiol. 38(3), 806-813 (2001). (Pubitemid 32835757)
52. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J. Am. Coll. Cardiol. 22(4), 955-962 (1993). (Pubitemid 23285742)
53. Packer M, Gheorghiade M, Young JB et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE study. N. Engl. J. Med. 329(1), 1-7 (1993). (Pubitemid 23182871)
54. Chun J, Chodosh J. Controversy in heart failure management: digoxin use in the elderly. J. Am. Med. Dir. Assoc. 7(9), 581-586 (2006). (Pubitemid 44661085)
55. Santangeli P, Di Biase L, Dello Russo A et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann. Intern. Med. 153(9), 592-599 (2010).
56. Healey JS, Hallstrom AP, Kuck KH et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur. Heart J. 28(14), 1746-1749 (2007). (Pubitemid 47227082)
57. Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur. J. Heart Fail. 7(5), 803-808 (2005). (Pubitemid 41125897)
58. Sayers SL, Hanrahan N, Kutney A et al. Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J. Am. Geriatr. Soc. 55, 1585-1591 (2007). (Pubitemid 47508502)
59. Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief 42, 1-8 (2010).
60. Brater DC. Resistance to loop diuretics. Why it happens and what to do about it. Drugs 30(5), 427-443 (1985). (Pubitemid 15240939)
61. Goodlin SJ. Palliative care in congestive heart failure. J. Am. Coll. Cardiol. 54(5), 386-396 (2009).
62. Notarius CF, Morris B, Floras JS. Caffeine prolongs exercise duration in heart failure. J. Card. Fail. 12(3), 220-226 (2006).
63. Chua TP, Harrington D, Ponikowski P, Webb-Peploe K, Poole-Wilson PA, Coats AJ. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J. Am. Coll. Cardiol. 29(1), 147-152 (1997). (Pubitemid 27028732)
64. Beniaminovitz A, Lang CC, LaManca J, Mancini DM. Selective low-level leg muscle training alleviates dyspnea in patients with heart failure. J. Am. Coll. Cardiol. 40(9), 1602-1608 (2002). (Pubitemid 35253638)
65. Goodlin SJ, Quill TE, Arnold RM. Communication and decision-making about prognosis in heart failure care. J. Card. Fail. 14(2), 106-113 (2008). (Pubitemid 351312888)
66. Moss AH Lunney JR, Culp S et al. Prognostic signif?icance of the surprise question in cancer patients. J. Palliative Med. 13(7), 837-840 (2010).
67. Riegel B, Dickson VV, Cameron J et al. Symptom recognition in elders with heart failure. J. Nurs. Scholar. 42(1), 92-100 (2010).
68. Riegel B, Moser DK, Anker SD et al. State of the Science: promoting self-care in persons with heart failure. Circulation 20(12), 1141-1163 (2009).
69. Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT) http://clinicaltrials.gov/ct/show/ NCT00094302?order=1 (Accessed 9 July 2011)